Company intelligence / Profile preview

ArrowDots BioMedicals

Newton, Massachusetts, United States

Ownership: Private
Development stage: Other

Overview

ArrowDots BioMedicals is an early-stage biotechnology company focused on developing advanced point-of-care diagnostic solutions using nanotechnology. Based in the Boston area, the company leverages a proprietary platform that utilizes specialized nanoparticles to enable rapid, sensitive, and cost-effective detection of various biomarkers. Their primary focus is on improving the speed and accuracy of diagnostics for oncology and infectious diseases. ArrowDots was a member of the LabShares Newton incubator, where it worked on refining its core technology for clinical applications.

Therapeutic areas: OncologyInfectious Diseases
Modalities: NanoparticleDiagnostic
Industry: Molecular Diagnostics

Beyond the preview

Go deeper on ArrowDots BioMedicals.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ArrowDots BioMedicals.

Explore the full profile